Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants
Clinical trial NCT06895993 · COMPLETED
Trial details
- NCT number
- NCT06895993
- Sponsor
- Sichuan Huiyu Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-07
- Primary completion
- 2025-05-08
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.